Our partnership combines the technical expertise of the development community with the business know-how of the private sector to save children’s lives and protect people’s health by increasing access to immunisation.
FOCUS AREAS Strategy 2016-2020 Partners Our Board Gender and immunisation Sustainable development goals
SUPPORTED COUNTRIESGavi supported a total of 73 countries in 2018Explore our country hub ->
Apply for support
Facts and figures
2021-2025 INVESTMENT OPPORTUNITY
Become a partner
Gavi Matching Fund
Sri Lanka and Timor-Leste team up for sustainable immunisation. By 2020, at least 20 developing countries are expected to transition out of Gavi support Read more ->
Tried and tested
2018 annual progress report > Download
Meet the newest ambassadors for immunisation: 10,000 Karachi schoolgirls 22 Nov 2019
Pakistan becomes first country to introduce new typhoid vaccine into routine immunisation program 15 Nov 2019
New partnership launched to increase uptake of life-saving vaccines in Rwanda 12 Nov 2019
Applying for vaccine support?
Safe and effective human papillomavirus (HPV) vaccines offer protection against up to 90% of all cervical cancer cases.
Gavi supports inactivated polio vaccine as part of routine immunisation programmes.
Gavi funds catch-up campaigns and routine introductions of the Japanese encephalitis vaccine.
The Gavi-funded measles-rubella vaccine provides a 2-in-1 shot against two devastating diseases.
Gavi-supported meningitis A vaccine campaigns have reached more than 268 million people.
Gavi helps to prevent cholera outbreaks through its support to the global oral cholera vaccine stockpile.
Find out more about Gavi’s support for the pentavalent vaccine, which protects against five deadly diseases.
Learn how Gavi helps countries fight pneumococcal disease - the leading cause of deadly pneumonia.
Gavi supports developing countries to introduce rotavirus vaccines, protecting against severe and deadly diarrhoea.
Gavi opened a funding window for typhoid conjugate vaccine in November 2017.
Gavi provides yellow fever support for routine immunisation, campaigns in high-risk countries and emergency stockpiles in case of outbreaks.
Apply for vaccine support